XZO

Exzeo Group, Inc.
10 filings tracked
industrialsprofessional servicesMICRO (<$300M)

Signal Magnitude Chart

BULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 80% | 5/7/2026 | margin expansionBULLISH | 70% | 5/7/2026 | earnings beatNEUTRAL | 30% | 5/7/2026 | dilution riskBULLISH | 70% | 5/15/2026 | margin expansionBULLISH | 60% | 5/15/2026 | earnings beatBEARISH | 80% | 5/15/2026 | margin compressionBULLISH | 70% | 5/15/2026 | margin expansionBULLISH | 60% | 5/15/2026 | earnings beatBEARISH | 80% | 5/15/2026 | margin compressionBULLISH | 60% | 5/26/2026 | buybackBEARISH | 30% | 5/26/2026 | capital raiseMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 26

Authorized $12 million share repurchase program under Rule 10b5-1.

buyback
60%
bearishMay 26

Potential liquidity risk as cash is diverted from operations to share repurchases.

capital raise
30%
bullishMay 15

Gross profit increased 13.6% as managed premium growth leverages a fixed cost structure.

margin expansion
70%
bullishMay 15

Net income grew 13.7% YoY to $20.4 million.

earnings beat
60%
bearishMay 15

SG&A expenses surged 92.8%, significantly increasing overhead as a percentage of revenue.

margin compression
80%
bullishMay 15

Gross profit increased 13.6% as managed premium growth leverages a fixed cost structure.

margin expansion
70%
bullishMay 15

Net income grew 13.7% YoY to $20.4 million.

earnings beat
60%
bearishMay 15

SG&A expenses surged 92.8%, significantly increasing overhead as a percentage of revenue.

margin compression
80%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%
bullishMay 7

Gross margins expanded 400 basis points to 59.0% driven by operating leverage.

margin expansion
80%
bullishMay 7

Net income grew to $20.4 million with strong Adjusted EBITDA of $28.3 million.

earnings beat
70%
neutralMay 7

New 2025 Omnibus Plan authorized 10 million shares for incentive awards.

dilution risk
30%

Filing History

8-KMay 26, 2026

The filing reveals a tension between management's desire to signal confidence and the reality of the company's liquidity constraints. While the authorization of a $12 million repurchase program provides an immediate bullish catalyst and potential price support, the discretionary nature of the plan and the company's emerging growth status introduce significant risk. Investors must now weigh the benefit of a reduced share count against the potential for cash starvation in a high-debt environment.

10-QMay 15, 2026

Exzeo Group's latest filing reveals a company at a crossroads between rapid technological scaling and the expensive realities of becoming a standalone public entity. The financial results are a study in contrasts: elite gross margins and a massive cash pile coexist with a staggering increase in SG&A expenses and extreme geographic concentration. The core IaaS platform is clearly delivering value, as seen in the growth of managed policies and premiums, but the cost of scaling that value is currently weighing on the operating margin. The ultimate trajectory for XZO depends on whether management can successfully diversify its revenue stream beyond Florida and stabilize its overhead costs. While the current net income is impressive, the reliance on investment income and affiliate-driven premiums introduces a layer of risk that offsets the technical strength of the platform. Investors are essentially betting on Exzeo's ability to execute a national expansion strategy without allowing the public-company cost structure to permanently erode its margin profile.

10-QMay 7, 2026

The Q1 10-Q paints a picture of a company at a critical crossroads: it possesses a high-performing technology product but remains an operational appendage of its parent company. The financial results are objectively strong, with net income of $20.4 million and a healthy Adjusted EBITDA margin of 51.5%. However, the extreme concentration of revenue and the prevalence of related-party transactions make it difficult to determine if Exzeo can maintain these margins in a truly competitive, arms-length market. For investors, the core tension lies in the speed of diversification. While the slight dip in related-party revenue is a positive signal, the company's ability to attract a critical mass of non-affiliated carriers is the only metric that truly validates the long-term bull case. Until the revenue mix shifts significantly, Exzeo will be viewed less as a diversified SaaS provider and more as a specialized service vehicle for the HCI ecosystem.